A comprehensive global evaluation demonstrates that COVID-19 vaccines proved to be a pivotal intervention, rescuing millions of lives predominantly among older adults, with the most substantial effects observed during the Omicron variant’s dominance. 
Credit: Shutterstock
Over the timeframe from 2020 to 2024, immunizations targeting SARS-CoV-2 successfully averted 2.533 million fatalities on a worldwide scale, achieving this by preventing one death for approximately every 5,400 vaccine doses delivered. Notably, 82% of these preserved lives belonged to individuals who received their vaccinations prior to any exposure to the virus. Furthermore, 57% of the prevented deaths occurred during the Omicron phase of the pandemic, while an impressive 90% of the beneficiaries were those aged 60 years and above. Collectively, these vaccines preserved a total of 14.8 million years of life, equating to one year of life saved for every 900 doses administered.
These striking figures emerge from an extensive investigation published in the esteemed journal JAMA Health Forum, spearheaded by Professor Stefania Boccia, who holds the position of Professor of General and Applied Hygiene at Università Cattolica del Sacro Cuore. The effort included vital contributions from Dr. Angelo Maria Pezzullo, a dedicated researcher in General and Applied Hygiene, and Dr. Antonio Cristiano, a medical resident specializing in Hygiene and Preventive Medicine. Both Pezzullo and Cristiano conducted collaborative work during their time at Stanford University, partnering closely with Professor John P.A. Ioannidis, the esteemed director of the Meta-Research Innovation Center (METRICS). This collaboration was facilitated through the “European network staff eXchange for integrAting precision health in the health Care sysTems- ExACT” initiative, which received funding from the European Research Excellence Programme RISE project under the Marie Skłodowska-Curie actions, all under the coordination of Professor Stefania Boccia.
Professor Boccia and Dr. Pezzullo elaborated on the significance of their findings by stating: “Prior to this research, numerous studies had attempted to quantify the lives preserved by COVID-19 vaccines, employing varied modeling approaches across different timeframes or geographic regions. However, our analysis stands out as the most thorough to date. It draws upon comprehensive global datasets, encompasses the critical Omicron era, quantifies not only lives but also years of life saved, and relies on minimal assumptions regarding the pandemic’s progression patterns.”
Details of the Research Methodology
The research team meticulously examined population-level data from across the globe, utilizing an array of sophisticated statistical techniques. Their goal was to determine the vaccination status of individuals who contracted COVID-19—whether they were vaccinated before or after infection, and whether this occurred before or during the Omicron period. They also assessed mortality rates and the ages at which deaths occurred. As Dr. Pezzullo detailed, “We juxtaposed these real-world observations with projections derived from models simulating a scenario devoid of COVID-19 vaccination programs. This comparison enabled us to precisely compute the number of lives spared by the vaccines and the corresponding extension in life expectancy gained through these interventions.”
The analysis further revealed that 76% of the total years of life saved were attributed to individuals over the age of 60. Interestingly, residents in long-term care facilities accounted for just 2% of the overall lives preserved. Contributions from younger demographics were minimal: children and adolescents represented only 0.01% of lives saved and 0.1% of life-years preserved, while young adults in the 20-29 age bracket contributed 0.07% of lives saved and 0.3% of life-years saved.
In her concluding remarks, Professor Boccia emphasized: “Our estimates adopt a notably conservative stance compared to earlier projections, which primarily focused on the initial year of vaccine rollout. Nevertheless, they unequivocally affirm the profound overall advantages of COVID-19 vaccination across the 2020-2024 period. The lion’s share of these benefits—both in terms of lives rescued and years of life extended—has been realized among the most vulnerable segments of the global population, namely the elderly.”
This study not only underscores the vaccines’ efficacy in averting deaths but also highlights their role in extending healthy lifespans, particularly for seniors who faced the highest risks from severe COVID-19 outcomes. By preventing infections before exposure in the majority of cases, the vaccination campaigns disrupted transmission chains and reduced hospitalization burdens worldwide. The inclusion of the Omicron period in the analysis is particularly valuable, as this variant posed unique challenges due to its high transmissibility and partial immune evasion properties.
The researchers’ approach minimized biases common in prior studies by leveraging broad, international datasets and rigorous statistical modeling. This methodology allowed for a more accurate depiction of vaccine impact across diverse populations, accounting for variations in age, geography, and pandemic waves. The conservative nature of the estimates adds credibility, suggesting that the true benefits may even exceed these figures.
For public health policymakers, these insights reinforce the critical importance of sustained vaccination efforts, especially targeting older adults. Even as the pandemic evolves, the data supports booster campaigns and equitable vaccine distribution to maximize life-saving potential. The minimal contribution from younger groups reflects the disease’s age-stratified severity, guiding resource allocation toward high-risk cohorts.
Looking ahead, this research sets a benchmark for evaluating future pandemic responses. It exemplifies how integrated international collaboration, advanced meta-research, and precise epidemiological tools can yield actionable evidence for global health strategies.
